Division of Emergency Medicine, Department of Pediatrics.
Pritzker Department of Psychiatry and Behavioral Sciences.
Pediatrics. 2023 Jul 1;152(1). doi: 10.1542/peds.2022-059586.
Pediatric mental health emergency department (ED) visits are rising in the United States, with more visits involving medication for acute agitation. Timely, standardized implementation of behavioral strategies and medications may reduce the need for physical restraint. Our objective was to standardize agitation management in a pediatric ED and reduce time in physical restraints.
A multidisciplinary team conducted a quality improvement initiative from September 2020 to August 2021, followed by a 6-month maintenance period. A barrier assessment revealed that agitation triggers were inadequately recognized, few activities were offered during long ED visits, staff lacked confidence in verbal deescalation techniques, medication choices were inconsistent, and medications were slow to take effect. Sequential interventions included development of an agitation care pathway and order set, optimization of child life and psychiatry workflows, implementation of personalized deescalation plans, and adding droperidol to the formulary. Measures include standardization of medication choice for severe agitation and time in physical restraints.
During the intervention and maintenance periods, there were 129 ED visits with medication given for severe agitation and 10 ED visits with physical restraint use. Among ED visits with medication given for severe agitation, standardized medication choice (olanzapine or droperidol) increased from 8% to 88%. Mean minutes in physical restraints decreased from 173 to 71.
Implementing an agitation care pathway standardized and improved care for a vulnerable and high-priority population. Future studies are needed to translate interventions to community ED settings and to evaluate optimal management strategies for pediatric acute agitation.
美国儿科精神科急诊就诊人次不断增加,其中涉及急性激越症状药物治疗的就诊人次有所增加。及时、标准化实施行为策略和药物治疗可能减少躯体约束的需求。我们的目的是规范儿科急诊激越管理,减少躯体约束的使用时间。
多学科团队于 2020 年 9 月至 2021 年 8 月开展了一项质量改进活动,随后进行了 6 个月的维持期。障碍评估显示,激越触发因素识别不足,急诊就诊时间长期间很少提供活动,工作人员对言语降级技术缺乏信心,药物选择不一致,药物起效缓慢。连续干预措施包括制定激越护理路径和医嘱集,优化儿童生活和精神病学工作流程,实施个性化降级计划,以及将氟哌啶醇纳入处方集。措施包括标准化严重激越的药物选择和躯体约束的使用时间。
在干预和维持期间,共有 129 例因严重激越而给予药物治疗的急诊就诊,10 例因躯体约束而就诊。在因严重激越而给予药物治疗的急诊就诊中,标准化药物选择(奥氮平或氟哌啶醇)从 8%增加到 88%。躯体约束的平均使用时间从 173 分钟减少到 71 分钟。
实施激越护理路径规范并改善了高危人群的护理。需要进一步研究将干预措施转化为社区急诊环境,并评估儿科急性激越的最佳管理策略。